Candida tropicalis engineering strain for synthesizing humulene and application
Through genetic engineering, the construction of the tropical Candida engineering strain is expressed, and the key genes are expressed to optimize the synthesis pathway of epene, which solves the problems of low production efficiency and environmental pollution in the existing technology, and achieves efficient production of epene Effect.
Patent Information
- Application Number
- CN202411189749.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-28
- Publication Date
- 2024-11-22
AI Technical Summary
In the prior art, the chemical synthesis process of α-piene is complex and environmentally contaminated, and the plant extraction method is inefficient and costly, making it difficult to meet the growing demand.
Genetic engineering constructs a tropical Candida engineered strain that efficiently produces venaeze through genetic engineering. The gene expression cassette includes related genes ERG10, ERG13, ERG12, ERG8, ERG19, ERG20 and ACHS2, respectively, and is expressed in the yeast cytoplasm or peroxisome, respectively. , optimize the sine synthesis pathway to improve yield.
It was achieved that 607.8 mg/L of crepene was obtained after fermentation of shake flask for 4 days, which significantly improved the yield and synthesis efficiency of crepene and had good industrial application prospects.
Smart Images

Figure CN118995458A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to an engineering strain of Candida tropicalis for synthesizing humulene and application thereof, belonging to the field of metabolic engineering. Background Art
[0002] α-Humulene, also known as α-caryophyllene or humulene, is a monocyclic terpene widely found in Humulus plants. It has multiple activities such as antibacterial, anti-cancer, and anti-diabetic. At the same time, humulene is also a precursor of terpenes such as zingerone, and can be used as a raw material to further produce other high value-added products.
[0003] Although α-humulene can be obtained through chemical synthesis, the process has many reaction steps and requires the use of expensive and environmentally harmful catalysts, which is not in line with the trend of green and sustainable development; its current commercial production is still mainly obtained through plant extraction, but there are problems such as low efficiency and high cost, and the plant growth cycle is long, which makes it difficult to meet the growing demand. As the main means of current synthetic biology research, the use of microorganisms to produce α-humulene heterologously has broad prospects. Therefore, constructing a humulene production strain with higher yield is of great significance for the industrial production and application of humulene and its derivatives. Summary of the invention
[0004] To solve the above problems, the present invention systematically constructs an engineered strain for efficiently producing humulene by means of genetic engineering, significantly increases the yield of humulene, improves its synthesis efficiency, and promotes its application in the fields of medicine, etc. In addition, the present invention also provides a method for constructing an engineered yeast strain for efficiently synthesizing sesquiterpenoid compounds.
[0005] The present invention provides a gene expression cassette for synthesizing humulene, wherein the gene expression cassette includes one or more "promoter-target gene-transcription terminator" structural units in sequence from upstream to downstream;
[0006] Wherein, the target gene includes:
[0007] Genes related to the synthesis of mevalonate from acetyl-CoA: ERG10 gene, ERG13 gene, tHMGR gene;
[0008] Genes related to the synthesis of IPP and DMAPP from mevalonate: ERG12 gene, ERG8 gene, ERG19 gene and IDI1 gene; or ERG12-ePTS gene, ERG8-ePTS gene, ERG19-ePTS gene and IDI1-ePTS gene in which the ePTS of the nucleotide sequence shown in SEQ ID NO.1 is connected to the 3' end of each gene respectively;
[0009] Genes related to the synthesis of humulene from IPP and DMAPP: ACHS1 gene and ERG20 gene; or ERG20-ePTS gene and ACHS2-ePTS gene whose nucleotide sequence is ePTS shown in SEQ ID NO.1 and connected to the 3' end of each gene.
[0010] In one embodiment, the expression cassette comprises:
[0011] (a) Using P GAP1 Promoter and T ENO1 The ERG10 gene was overexpressed by using P GAP1 Promoter and T 7syn terminator to overexpress tHMGR gene, and P FBA1 Promoter and T PGK1 Expression cassette for overexpression of ERG13 gene by terminator FAO1-gda324-URA3-T ENO1 -ERG10-P GAP1 -T 7syn -tHMGR-P GAP1 -P FBA1 -ERG13-T PGK1 -FAO1, named cytoplasmic expression cassette 1C;
[0012] (b) Using P GAP1 Promoter and T ENO1 The terminator overexpressed the IDI1 gene. FBA1 Promoter and T ADH2 The terminator was used to overexpress the ERG19 gene. GAP1 Promoter and T 7syn terminator to overexpress the ERG8 gene, and using P FBA1 Promoter and T PGK1 Terminator overexpression cassette for ERG12 gene ALD1-gda324-URA3-T ENO1 -IDI1-P GAP1 -P FBA1 -ERG19-T ADH2 -T 7syn -ERG8-P GAP1 -P FBA1 -ERG12-T PG K1 -ALD1, designated as cytoplasmic expression cassette 2C; or
[0013] After ePTS was connected to the 3' end of ERG12, ERG8, ERG19, and IDI1 genes, P GAP1 Promoter and T ENO1 The terminator overexpressed the IDI1-ePTS gene and PFBA1 Promoter and T ADH2 The ERG19-ePTS gene was overexpressed by using P GAP1 Promoter and T 7syn terminator to overexpress the ERG8-ePTS gene, and P FBA1 Promoter and T PGK1 Terminator overexpression cassette for ERG12-ePTS gene ALD1-gda324-URA3-T ENO1 -ePTS-IDI1-P GAP1 -P FBA1 -ERG19-ePTS-T ADH2 -T 7syn -ePTS-ERG8-P GAP1 -P FBA1 -ERG12-ePTS-T PGK1 -ALD1, named peroxisome expression cassette 2P;
[0014] (c) Using P GAP1 Promoter and T 7syn The terminator was used to overexpress the ERG20 gene. FBA1 Promoter and T ADH2 Expression cassette for overexpression of ACHS2 gene by terminator POX5-gda324-URA3-P FBA1 -ACHS2-T ADH2 -T 7syn -ERG20-P GAP1 -POX5, named cytoplasmic expression cassette III-HC; or
[0015] After ePTS was connected to the 3' end of ERG20 and ACHS2 genes, P GAP1 Promoter and T 7syn The ERG20-ePTS gene was overexpressed by using P FBA1 Promoter and T ADH2 The expression cassette for overexpression of ACHS2-ePTS gene is POX5-gda324-URA3-P FBA1 -ACHS2-ePTS1-T ADH2 -T 7syn -ePTS1-ERG20-P GAP1 -POX5, named peroxisome expression cassette III-HP.
[0016] In one embodiment, the genbank accession number of the gene ERG10 is: D13470.1, the genbank accession number of the gene ERG13 is: RCK66100.1, the genbank accession number of the gene tHMGR is: RCK56388.1; the genbank accession number of the gene ERG20 is: RCK67668.1, and the nucleotide sequence of the gene ACHS2 is shown in SEQ ID NO.2; the genbank accession number of the gene ERG12 is: RCK63831.1, the genbank accession number of the gene ERG8 is: RCK59297.1, the genbank accession number of the gene ERG19 is: RCK60630.1, and the genbank accession number of the gene IDI1 is: RCK59267.1.
[0017] The present invention provides a recombinant Candida tropicalis, wherein the recombinant Candida tropicalis has a humulene synthesis pathway gene integrated into the genome of a starting strain, comprising:
[0018] (a) Genes related to the synthesis of mevalonate from acetyl-CoA: including acetyl-CoA thiolase gene ERG10, HMG-CoA synthetase gene ERG13 and HMG-CoA reductase gene tHMGR, and expressed in yeast cytoplasm; the genbank accession number of the gene ERG10 is: D13470.1, the genbank accession number of the gene ERG13 is: RCK66100.1, and the genbank accession number of the gene tHMGR is: RCK56388.1;
[0019] (b) Genes related to the synthesis of IPP and DMAPP from mevalonate: including mevalonate kinase gene ERG12, phosphomevalonate kinase gene ERG8, diphosphomevalonate kinase gene ERG19 and isopentenyl pyrophosphate isomerase gene IDI1, and overexpressed in the cytoplasm or peroxisome; the genbank accession number of the ERG12 gene is: RCK63831.1, the genbank accession number of the ERG8 gene is: RCK59297.1, the genbank accession number of the ERG19 gene is: RCK60630.1, and the genbank accession number of the IDI1 gene is: RCK59267.1;
[0020] (c) Genes related to humulene synthase from IPP and DMAPP: including geranyl / farnesyl pyrophosphate synthase gene ERG20 and agarwood-derived humulene synthase gene ACHS2, and overexpressed in yeast peroxisomes; the genbank accession number of the gene ERG20 is: RCK67668.1, and the nucleotide sequence of the gene ACHS2 is shown in SEQ ID NO.2.
[0021] In one embodiment, the starting strain includes but is not limited to Candida tropicalis ATCC20336 or Candida tropicalis CU-206; the Candida tropicalis CU-206 is prepared by transforming Candida tropicalis ATCC20336, and its construction method is recorded in the paper "Lihua Zhang, et al. 2020, A CRISPR-Cas9 system for multiple genome editing and pathway assembly in Candida tropicalis. Biotechnol Bioeng, 117: 531-542".
[0022] In one embodiment, the overexpressed gene is integrated into yeast chromosome DNA through homologous recombination for stably expression, and the number of copies of the gene integrated into the yeast chromosome is 2 to 4.
[0023] In one embodiment, the recombinant Candida tropicalis is obtained by integrating the cytoplasmic expression cassette 1C, the cytoplasmic expression cassette 2C or the peroxidase expression cassette 2P, and the cytoplasmic expression cassette III-HC or the peroxidase expression cassette III-HP into any site on the Candida tropicalis genome that does not affect its growth.
[0024] In one embodiment, the recombinant Candida tropicalis is obtained by integrating the cytoplasmic expression cassette 1C, the peroxisomal expression cassette 2P and the peroxisomal expression cassette III-HP into any site on the Candida tropicalis genome that does not affect its growth.
[0025] In one embodiment, the site of integration into the Candida tropicalis genome includes, but is not limited to, the FAO1 site, the ALD1 site, the POX5 site, and the DLD1-2 site.
[0026] In one embodiment, the recombinant Candida tropicalis integrates expression cassette 3C expressing ERG20 and ACHS2, or expression cassette 3P expressing ERG20 and ACHS2 containing the nucleotide sequence as shown in SEQ ID NO.1 into the POX5 site of the Candida tropicalis genome; and integrates expression cassette 2C expressing ERG12, ERG8, ERG19 and IDI1, or expression cassette 2P expressing ERG12, ERG8, ERG19 and IDI1 containing the nucleotide sequence as shown in SEQ ID NO.1 into the ALD1 site of the Candida tropicalis genome; and integrates expression cassette 1C expressing ERG10, ERG13 and tHMGR into the FAO1 site of the Candida tropicalis genome.
[0027] In one embodiment, expression cassette III-HP is integrated into the POX5 site of the Candida tropicalis genome, expression cassette 2P is integrated into the ALD1 site of the Candida tropicalis genome, and expression cassette 1C is integrated into the FAO1 site of the Candida tropicalis genome.
[0028] In one embodiment, ERG10, ERG13 and tHMGR in the humulene biosynthesis pathway are expressed in the yeast cytoplasm; and ERG12, ERG8, ERG19, IDI1, ERG20, and ACHS2 are overexpressed in the yeast peroxisome.
[0029] In one embodiment, ERG10, ERG13, tHMGR, ERG12, ERG8, ERG19 and IDI1, ERG20, ACHS2 in the humulene biosynthesis pathway are expressed in the yeast cytoplasm.
[0030] In one embodiment, the genes ERG10, ERG13 and tHMGR are integrated and expressed at the FAO1 site, the genes ERG12, ERG8, ERG19 and IDI1 are integrated and expressed at the ALD1 site, and the genes ERG20 and ACHS2 are integrated and expressed at the POX5 site.
[0031] In one embodiment, overexpression of ERG20 and ACHS2 at the DLD1-2 locus further enhances the humulene production capacity of the strain.
[0032] The present invention provides a method for increasing the yield of humulene synthesized by Candida tropicalis, the method comprising the following steps:
[0033] (1) Overexpressing genes related to the synthesis of mevalonate from acetyl-CoA in the cytoplasm of Candida tropicalis to obtain engineered bacteria 1;
[0034] (2) overexpressing genes related to the synthesis of IPP and DMAPP from mevalonate in the cytoplasm of engineered bacteria 1 to obtain engineered bacteria 2-1; or overexpressing genes related to the synthesis of IPP and DMAPP from mevalonate in the peroxisome of engineered bacteria 1 to obtain engineered bacteria 2-2;
[0035] (3) Overexpression of genes related to IPP and DMAPP to humulene synthase in the cytoplasm of engineered bacteria 2-1 or in the peroxisome of engineered bacteria 2-2.
[0036] In one embodiment, the method comprises the following steps:
[0037] (1) At any site on the Candida tropicalis genome that does not affect its growth, use P GAP1 Promoter and T ENO1 The ERG10 gene was overexpressed by using P GAP1 Promoter and T 7syn terminator to overexpress tHMGR gene, and P FBA1 Promoter and T PGK1 The terminator overexpressed the ERG13 gene to obtain engineered bacteria 1;
[0038] (2) At any site on the genome of engineered bacteria 1 that does not affect its growth, use P GAP1 Promoter and T ENO1 The terminator overexpressed the IDI1 gene. FBA1 Promoter and T ADH2 The terminator was used to overexpress the ERG19 gene. GAP1 Promoter and T 7syn terminator to overexpress the ERG8 gene, and using P FBA1 Promoter and T PGK1 The terminator overexpressed the ERG12 gene to obtain the engineered bacteria 2-1;
[0039] (3) After the nucleotide sequence of ePTS shown in SEQ ID NO.1 was connected to the 3' end of ERG20 and ACHS2 genes respectively, P was used at any site on the genome of the engineered bacterium 2-1 that did not affect its growth. GAP1 Promoter and T 7syn The terminator was used to overexpress the ERG20 gene. FBA1 Promoter and T ADH2 terminator overexpresses the ACHS2 gene.
[0040] In one embodiment, the method comprises the following steps:
[0041] (1) At any site on the Candida tropicalis genome that does not affect its growth, use P GAP1 Promoter and TENO1 The ERG10 gene was overexpressed by using P GAP1 Promoter and T 7syn terminator to overexpress tHMGR gene, and P FBA1 Promoter and T PGK1 The terminator overexpressed the ERG13 gene to obtain engineered bacteria 1;
[0042] (2) After the nucleotide sequence of ePTS shown in SEQ ID NO.1 was connected to the 3' end of ERG12, ERG8, ERG19, and IDI1 genes, P was used at any site on the genome of the engineered bacteria 1 that did not affect its growth. GAP1 Promoter and T ENO1 The terminator overexpressed the IDI1-ePTS gene and P FBA1 Promoter and T ADH2 The ERG19-ePTS gene was overexpressed by using P GAP1 Promoter and T 7syn terminator to overexpress the ERG8-ePTS gene, and P FBA1 Promoter and T PGK1 The terminator overexpressed the ERG12-ePTS gene to obtain the engineered bacteria 2-2;
[0043] (3) After the nucleotide sequence of ePTS as shown in SEQ ID NO.1 was connected to the 3' end of ERG20 and ACHS2 genes respectively, P was used at any site on the genome of the engineered bacterium 2-2 that did not affect its growth. GAP1 Promoter and T 7syn The ERG20-ePTS gene was overexpressed by using P FBA1 Promoter and T ADH2 terminator overexpresses the ACHS2-ePTS gene.
[0044] The present invention also provides the use of the recombinant Candida tropicalis in the fermentation production of humulene.
[0045] In one embodiment, the fermentation medium is YPD60 medium.
[0046] In one embodiment, the method is to culture the yeast engineered strain in YPD, prepare seed liquid when OD600 reaches 12 to 16, transfer the prepared seed liquid to the fermentation medium at a ratio of 5% to 12% (v / v), and then ferment at 25 to 40° C. for at least 48 hours.
[0047] In one embodiment of the present invention, the product is food, medicine or chemical raw material.
[0048] Beneficial Effects
[0049] (1) Starting from industrial production strains, the present invention uses synthetic biology technology and metabolic engineering to construct a yeast engineering strain that efficiently synthesizes humulene. With glucose as the main carbon source, 607.8 mg / L humulene was obtained after 4 days of shake flask fermentation, which has good industrial application prospects.
[0050] (2) The present invention first discovered and proved that expressing ERG10, ERG13 and tHMGR (corresponding to the genes from acetyl-CoA to mevalonate in the metabolic pathway) in the humulene synthesis pathway in the yeast cytoplasm, overexpressing ERG20, ACHS2 and SmKSL1 (corresponding to the genes from IPP and DMAPP to humulene in the metabolic pathway) in the yeast peroxisome, and overexpressing ERG12, ERG8, ERG19 and IDI1 (corresponding to the genes from mevalonate to IPP and DMAPP in the metabolic pathway) in the peroxisome is an effective way to construct a humulene synthesis strain. BRIEF DESCRIPTION OF THE DRAWINGS
[0051] Figure 1 : Shake flask fermentation yield of humulene in metabolically modified engineered strains of Candida tropicalis.
[0052] Figure 2 : Comparative example of the fermentation yield of humulene by the engineered strains of Candida utilis and Candida tropicalis. DETAILED DESCRIPTION
[0053] The present invention will be further described below in conjunction with specific embodiments.
[0054] The tropical Candida CU-206 strain and CRISPR-Cas9 gene editing vector and its construction method involved in the following embodiments are all recorded in the document "Lihua Zhang, et al. 2020, A CRISPR-Cas9 system for multiple genome editing and pathway assembly in Candida tropicalis. Biotechnol Bioeng, 117: 531-542"; plasmid Ts-PFBA1-carB-TFBA1 and its construction method are disclosed in the patent with publication number CN109652388B; plasmid Ts-POX5-gda324-URA3 and its construction method are recorded in the degree thesis "Establishment of tropical Candida genetic operating system and its application in dibasic acid synthesis"; plasmid Tm-gda324-URA3 and its construction method are recorded in the document "Lihua Zhang, et al. 2016, Development of an efficient genetic manipulation strategy for sequential gene disruption and expression of different heterologous GFP genes in Candida tropicalis. Appl Microbiol Biot, 100(22):9567-9580”; pMD19-T vector was purchased from Takara Biotechnology (Dalian) Co., Ltd.
[0055] The culture medium involved in the following examples is as follows:
[0056] Basic culture medium (MM medium): YNB 6.7 g·L -1 , ammonium sulfate 10g·L -1 , glucose 20g·L -1 .
[0057] Supplementary medium (SM medium): YNB 6.7 g·L -1 , ammonium sulfate 10g·L -1 , glucose 20g·L -1 , uracil 0.06 g·L -1 .
[0058] FOA tablet: YNB 6.7g·L -1 , ammonium sulfate 10g·L -1 , glucose 20g·L -1 , uracil 0.06 g·L -1, 5-fluoroorotic acid 0.2 g·L -1 .
[0059] YPD medium: 20 g L -1 Glucose, 10 g L -1 Peptone, 5 g L -1 Yeast powder.
[0060] YPD60 medium: 60 g·L -1 Glucose, 10 g L -1 Peptone, 5 g L -1 Yeast powder.
[0061] The detection methods involved in the following embodiments are as follows:
[0062] Determination of humulene production:
[0063] 1. Extraction
[0064] Take 20 mL of fermentation broth and ultrasonically disrupt the cells, then add 20 mL of n-hexane and shake vigorously for 5 minutes to extract humulene. Centrifuge at 5000 rpm for 5 minutes, and collect the upper organic phase for detecting the humulene content.
[0065] 2. Detection
[0066] Take 500 μL of n-hexane organic phase and filter it with a 0.22 μm organic filter membrane, and analyze it with a high-resolution gas chromatography-mass spectrometer. The detection method of humulene is as follows: the initial column temperature is 50°C and maintained for 1 minute; then the temperature is increased to 240°C at a rate of 10°C / min, and then the temperature is increased to 280°C at a rate of 20°C / min, and maintained at 280°C for 8 minutes. The mass spectrometry data is collected under full scan mode (m / z30-350) to obtain the detection data.
[0067] The experimental methods not specifically noted in the following examples can be completed according to conventional methods or the instructions of the manufacturers of the products used. The materials, reagents, etc. used can be obtained through commercial channels unless otherwise specified.
[0068] Example 1: Construction and application of expression cassette for expressing genes in cytoplasm
[0069] 1. Construction of the integration expression cassette for co-expression of ERG20 and ACHS2:
[0070] (1) The codons of the humulene synthase gene ACHS2 (GenBank accession number: EF635966.2) from Aquilaria sinensis were optimized and fully chemically synthesized according to the codon preference of Candida tropicalis to obtain an optimized humulene synthase gene (ACHS2, the nucleotide sequence of which is shown in SEQ ID NO. 2). The ACHS2 gene was then inserted into the plasmid PBE01 (the plasmid PBE01 and its construction method are disclosed in the patent application document with publication number CN114277040A) to replace the original gene BTS1, and a recombinant plasmid PBE01 was obtained. GAP1 -ERG20-T 7syn -T ADH2 -ACHS2-P FBA1 (abbreviated as PAE01);
[0071] (2) Use NotI to digest plasmid PAE01 and recover ERG20 and ACHS2 gene expression cassettes GAP1 -ERG20-T 7syn -T ADH2 -ACHS2-P FBA1 , and then inserted into the EcoRI restriction site of the recombinant plasmid Ts-POX5-gda324-URA3 (the plasmid and its construction method are disclosed in the document "Zhang Lihua, 2016 Master's thesis of Jiangnan University, Establishment of tropical Candida genetic operating system and its application in dibasic acid synthesis") through blunt-end ligation to obtain the recombinant plasmid Ts-POX5-gda324-URA3--T ENO1 --P GAP1 -P FBA1 -ACHS2-T ADH2 -T 7syn -ERG20-P GAP1 -P FBA1 -SmKSL1-T PGK1 (abbreviated as POX5-PAE-01);
[0072] (4) The plasmid POX5-PAE-01 was digested with Mlu I to obtain the linearized ERG20 and ACHS2 integration expression cassette POX5-gda324-URA3-P FBA1 -ACHS2-T ADH2 -T 7syn -ERG20-P GAP1 -POX5; named expression cassette III-HC.
[0073] 2. Construction of an integrated expression cassette for co-expression of ERG12, ERG8, ERG19 and IDI1 in the cytoplasm
[0074] Referring to the patent application document with publication number CN114277040A, a 4-gene co-expression integration cassette ALD1-gda324-URA3-T was constructed. ENO1 -IDI1-P GAP1 -P FBA1 -ERG19-T ADH2 -T 7syn -ERG8-P GAP1 -P FBA1 -ERG12-T PG K1 -ALD1 (abbreviated as 2C).
[0075] 3. Construction of the integrated expression cassette for expressing ERG10, ERG13 and tHMGR in the cytoplasm
[0076] Referring to the patent application document with publication number CN114277040A, an integrated expression cassette FAO1-gda324-URA3-T for co-expression of three genes was constructed ENO1 -ERG10-P GAP1 -T 7syn -tHMGR-P GAP1 -P FBA1 -ERG13-T PGK1 -FAO1; designated as expression cassette 1C.
[0077] 4. Construction of humulene-producing engineered strain 1C2C3C
[0078] (1) Using CRISPR-Cas9 technology, linearized ERG10, ERG13, and tHMGR were integrated into the expression cassette (1C) FAO1-gda324-URA3-T ENO1 -ERG10-P GAP1 -T 7syn -tHMGR-P GAP1 -P FBA1 -ERG13-T PGK1 -FAO1 was transformed into Candida tropicalis CU-206 (disclosed in the document "Lihua Zhang, et al. 2020, A CRISPR-Cas9 system for multiple genome editing and pathway assembly in Candida tropicalis. Biotechnol Bioeng, 117: 531-542"), two copies of ERG10, ERG13 and tHMGR genes were integrated at the FAO1 site, and strain DC-01 was obtained by PCR screening;
[0079] (2) The mutant strain DC-02 after the URA3 gene was lost in strain DC-01 was constructed according to the method of “Lihua Zhang, et al. 2016, Development of an efficient genetic manipulation strategy for sequential gene disruption and expression of different heterologous GFP genes in Candida tropicalis. Appl Microbiol Biot, 100(22): 9567-9580”;
[0080] (3) Using CRISPR-Cas9 technology, the linearized ERG8, ERG19, ERG12 and IDI1 genes were integrated into the expression cassette (2C) ALD1-gda324-URA3-TENO1-IDI1-P GAP1 -PFBA1-ERG19-TADH2-T7syn-ERG8-P GAP1 -PFBA1-ERG12-TPGK1-ALD1 was integrated into the ALD1 locus of strain DC-02 to obtain strain DC-03;
[0081] (4) Constructing a mutant strain DC-04 in which the URA3 gene of strain DC-03 is lost by the same method as step (2);
[0082] (5) Using CRISPR-Cas9 technology, the linearized ERG20 and ACHS2 genes were integrated into the expression cassette (III-HC) POX5-gda324-URA3-P FBA1 -ACHS2-T ADH2 -T 7syn -ERG20-P GAP1 -POX5 was integrated into the POX5 locus of Candida tropicalis strain DC-04 to obtain strain DC04-DC-H101.
[0083] Example 2: Construction of humulene-producing engineered strains
[0084] 1. Construction of an integrated expression cassette for co-expression of ERG20 and ACHS2 in peroxisomes
[0085] (1) The peroxisome localization signal peptide coding sequence ePTS (nucleotide sequence as shown in SEQ ID NO. 1) was added to the 3' end of ACHS2 and ERG20 genes in the recombinant plasmid PAE01 using the one-step cloning kit C113 to construct a recombinant plasmid; Ts-P FBA1-ACHS2-ePTS-T ADH2 -T 7syn -ePTS-ERG20-P GAP1 (abbreviated as PAE03);
[0086] (2) The recombinant plasmid PAE03 was digested with MluI to recover the ERG20 and ACHS2 gene expression cassettes P FBA1 -ACHS2-ePTS-T ADH2 -T 7syn -ePTS-ERG20-P GAP1 , and then inserted into the EcoRI restriction site of the recombinant plasmid Ts-POX5-gda324-URA3 by blunt-end ligation to obtain the recombinant plasmid POX5-PAE-03;
[0087] (3) The plasmid POX5-PAE-03 was digested with Mlu I to obtain the linearized ERG20 and ACHS2 integration expression cassette POX5-gda324-URA3-P FBA1 -ACHS2-ePTS-T ADH2 -T 7syn -ePTS-ERG20-P GAP1 -POX5; named as expression cassette III-HP (integration site is POX5).
[0088] 2. Construction of an integrated expression cassette for co-expression of ERG12, ERG8, ERG19 and IDI in peroxisomes
[0089] Referring to the patent publication number CN114277040A, a 4-gene co-expression integration cassette 2P was constructed: ALD1-gda324-URA3-T ENO1 -ePTS-IDI1-P GAP1 -P FBA1 -ERG19-ePTS-T ADH2 -T 7syn -ePTS-ERG8-P GAP1 -P FBA1 -ERG12-ePTS-T PGK1 -ALD1.
[0090] The linearized ERG8, ERG19, ERG12 and IDI1 genes were integrated into the expression cassette ALD1-gda324-URA3-T using CRISPR-Cas9 technology. ENO1 -ePTS-IDI1-P GAP1 -P FBA1 -ERG19-ePTS-T ADH2 -T 7syn -ePTS-ERG8-PGAP1 -P FBA1 -ERG12-ePTS-T PGK1 -ALD1 (2P expression cassette) and linearized ERG20 and ACHS2 integration expression cassettes POX5-gda324-URA3-T ENO1 -ePTS--P GAP1 -P FBA1 -ACHS2-ePTS-T ADH2 -T 7syn -ePTS-ERG20-P GAP1 -P F BA1 -SmKSL1-ePTS-T PGK1 -POX5 (3P expression cassette) was sequentially transformed into Candida tropicalis DC-02 (containing 1C expression cassette) constructed in Example 1 to obtain strain 1C2P-DP-H101.
[0091] The strain 1C2P-DP-H102 was constructed by referring to the method of Example 1 after the URA3 marker was removed from the strain 1C2P-DP-H101.
[0092] Example 3: Fermentation of humulene-producing engineered strains
[0093] Single colonies of strain DC04-DC-H01 constructed in Example 1 and strain 1C2P-DP-H101 constructed in Example 2 were picked up respectively into 20 mL of fresh YPD medium and cultured at 30° C. and 200 rpm as seed solution;
[0094] When the seed solution OD 600 After reaching 12-15, the cells were transferred to a shake flask containing 30 mL of YPD60 medium at a ratio of 5% (v / v) and fermented at 30°C and 200 rpm for 4 days.
[0095] After fermentation, humulene was extracted and tested. The humulene yields of the engineered strains DC04-DC-H101 and 1C2P-DP-H101 were 147.8 mg·L -1 、426.0mg·L -1 (like Figure 1 As shown in Figure 3, the humulene production of strain 1C2P-DP-H101 was 2.88 times that of the full-cytoplasmic strain DC04-DC-H101.
[0096] Example 4: Construction and application of humulene-producing engineered strains 1C2P-TP-H103 and 1C2P-FP-H104
[0097] 1. Construction of expression cassette:
[0098] Referring to the patent application document with publication number CN114277040A, plasmid Ts-DLD1-2-gda324-URA3 was constructed;
[0099] (1) Digest the recombinant plasmid PAE03 with MluI to recover the ERG20 and ACHS2 gene expression cassettes P FBA1 -ACHS2-ePTS-T ADH2 -T 7syn -ePTS-ERG20-P GAP1 , and then inserted into the EcoRI restriction site of the recombinant plasmid Ts-DLD1-2-gda324-URA3 through blunt-end ligation to obtain the recombinant plasmid DLD1-2-PAE-03;
[0100] (2) The plasmid DLD1-2-PAE-03 was digested with Mlu I to obtain the linearized ERG20 and ACHS2 integration expression cassette DLD1-2-gda324-URA3-P with the target integration site DLD1-2. FBA1 -ACHS2-ePTS-T ADH2 -T 7syn -ePTS-ERG20-P GAP1 -DLD1-2 (the integration site is the III-HP expression cassette of DLD1-2).
[0101] 2. Construction and fermentation of humulene-producing engineered strains 1C2P-TP-H103 and 1C2P-FP-H104
[0102] The expression cassette DLD1-2-gda324-URA3-P was transformed into FBA1 -ACHS2-ePTS-T ADH2 -T 7syn -ePTS-ERG20-P GAP1 -DLD1-2 was transformed into the tropical Candida 1C2P-DP-H102 constructed in Example 2, and further obtained the engineered strain 1C2P-TP-H103 with a total of 3 copies of III-HP and the engineered strain 1C2P-FP-H104 with 4 copies of III-HP.
[0103] Pick up single colonies of 1C2P-TP-H103 and 1C2P-FP-H104 into 20 mL of fresh YPD medium and culture them at 30°C and 200 rpm as seed solution. 600 After reaching 12-15, the mixture was transferred to a shake flask containing 30 mL of YPD60 medium at a ratio of 5% (v / v) and fermented at 30°C and 200 rpm for 4 days.
[0104] After fermentation, humulene was extracted and tested. The humulene yields of strains 1C2P-TP-H103 and 1C2P-FP-H104 were 526.6 mg·L -1 、607.8mg·L -1 (like Figure 1 shown).
[0105] Comparative Example 1
[0106] Specific implementation method The same as Example 1, except that the host Candida tropicalis CU-206 is replaced by Candida utilis ATCC 9226, Candida tropicalis CICIM Y7065, Candida tropicalis CICIM Y7071, Candida tropicalis CICIM Y7146, and the constructed full cytoplasm localization strains are named 9226-DCH, 7065-DCH, 7071-DCH, 7146-DCH. The strains 9226-DCH, 7065-DCH, 7071-DCH, and 7146-DCH are fermented and tested according to the method of Example 3.
[0107] The results showed that the humulene production of strain 9226-DCH was 50.6 mg·L -1 The strain 7065-DCH yield was 112.3 mg·L -1 (like Figure 2 The strain 7071-DCH yield was 109.8 mg·L -1 The strain 7146-DCH yield was 114.1 mg·L -1 , indicating that tropical Candida is the preferred species for constructing humulene-producing recombinant bacteria using the method of this patent, and among different strains of tropical Candida, ATCC 20336 is the best choice, which is one of the characteristics of the present invention in achieving higher yields.
[0108] Although the present invention has been disclosed as above in the form of a preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. Recombinant Candida tropicalis, It is characterized in that The genes of the humulene biosynthesis pathway are overexpressed in the genome of the starting strain, including: (a) Genes related to the synthesis of acetyl-CoA to mevalonate: including acetyl-CoA thiolase gene ERG10, HMG-CoA synthetase gene ERG13 and HMG-CoA reductase gene tHMGR; (b) Genes involved in the synthesis of IPP and DMAPP from mevalonate: including mevalonate kinase gene ERG12, phosphomevalonate kinase gene ERG8, diphosphomevalonate kinase gene ERG19, and isopentenyl pyrophosphate isomerase gene IDI1; (c) From IPP and DMAPP to humulene synthase-related genes: including the geranyl / farnesyl pyrophosphate synthase gene ERG20 and the agarwood-derived humulene synthase gene ACHS2.
2. The recombinant Candida tropicalis according to claim 1, It is characterized in that Integrate and express the gene expression cassette containing the gene into the genome of the starting strain; The gene expression cassette includes one or more "promoter-target gene-transcription terminator" structural units from upstream to downstream; the target gene includes: Genes related to the synthesis of mevalonate from acetyl-CoA: ERG10 gene, ERG13 gene, tHMGR gene; Genes related to the synthesis of IPP and DMAPP from mevalonic acid: ERG12 gene, ERG8 gene, ERG19 gene and IDI1 gene; or ERG12-ePTS gene, ERG8-ePTS gene, ERG19-ePTS gene and IDI1-ePTS gene with the nucleotide sequence of ePTS shown in SEQ ID NO.1 connected to the 3' end of the gene; Genes related to the synthesis of humulene from IPP and DMAPP: ERG20 gene and ACHS2 gene; or ERG20-ePTS gene and ACHS2-ePTS gene with the nucleotide sequence of ePTS shown in SEQ ID NO.1 connected to the 3' end of the gene.
3. The recombinant Candida tropicalis according to claim 1 or 2, It is characterized in that Sites for integration into the Candida tropicalis genome include, but are not limited to, the FAO1 site, the ALD1 site, the POX5 site, and the DLD1-2 site.
4. The recombinant Candida tropicalis according to any one of claims 1 to 3, It is characterized in that The overexpression is to integrate the gene into yeast chromosome DNA through homologous recombination for stable expression, and the number of copies of the gene integrated into the yeast chromosome is 2 to 4.
5. The recombinant Candida tropicalis according to any one of claims 1 to 4, It is characterized in that The starting strains include but are not limited to Candida tropicalis ATCC20336 or Candida tropicalis CU-206.
6. A method for increasing the yield of humulene synthesized by Candida tropicalis, It is characterized in that The following steps are involved: (1) Overexpressing genes related to the synthesis of mevalonate from acetyl-CoA in the cytoplasm of Candida tropicalis to obtain engineered bacteria 1; (2) overexpressing genes related to the synthesis of IPP and DMAPP from mevalonic acid in the cytoplasm of the engineered bacterium 1 constructed in step (1) to obtain engineered bacterium 2-1; or Overexpressing genes related to the synthesis of IPP and DMAPP from mevalonic acid in the peroxisome of the engineered bacteria 1 to obtain the engineered bacteria 2-2; (3) Overexpressing genes related to IPP and DMAPP to humulene synthase in the cytoplasm of the engineered bacteria 2-1 described in step (2) or in the peroxisome of the engineered bacteria 2-2.
7. The method according to claim 6, It is characterized in that The following steps are involved: (1) At any site on the Candida tropicalis genome that does not affect its growth, use P GAP1 Promoter and T ENO1 The ERG10 gene was overexpressed by using P GAP1 Promoter and T 7syn terminator to overexpress tHMGR gene, and P FBA1 Promoter and T PGK1 The terminator overexpressed the ERG13 gene to obtain engineered bacteria 1; (2) After the nucleotide sequence of ePTS as shown in SEQ ID NO.1 was connected to the 3' end of ERG12, ERG8, ERG19, and IDI1 genes respectively, P was used at any site on the genome of the engineered bacteria 1 that did not affect its growth. GAP1 Promoter and T ENO1 The terminator overexpressed the IDI1-ePTS gene and P FBA1 Promoter and T ADH2 The ERG19-ePTS gene was overexpressed by using P GAP1 Promoter and T 7syn terminator to overexpress the ERG8-ePTS gene, and P FBA1 Promoter and T PGK1 The terminator overexpressed the ERG12-ePTS gene to obtain the engineered bacteria 2-2; (3) After the nucleotide sequence of ePTS as shown in SEQ ID NO.1 was connected to the 3' end of ERG20 and ACHS2 genes respectively, P was used at any site on the genome of the engineered bacterium 2-2 that did not affect its growth. GAP1 Promoter and T 7syn The ERG20-ePTS gene was overexpressed by using P FBA1 Promoter and T ADH2 terminator overexpresses the ACHS2-ePTS gene.
8. A method for preparing humulene, It is characterized in that The recombinant Candida tropicalis according to any one of claims 1 to 5 is used for fermentation in a culture medium with glucose as a carbon source.
9. The method according to claim 8, It is characterized in that The recombinant Candida tropicalis is cultured in YPD to prepare a seed solution, and the seed solution is then transferred to a fermentation medium and then fermented at 25-40° C. for at least 48 hours.
10. Use of the recombinant Candida tropicalis according to any one of claims 1 to 5, or the method according to any one of claims 7 to 9 in the preparation of humulene or a product containing humulene.
